Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Theanine and Reduced Anxiety

Research synthesisLow evidenceSmall effect6 studies · 2 beneficial · 4 neutral · 0 harmful

Across 6 studies, 2 found beneficial moderate-sized effects on anxiety reduction, while 4 found no significant benefit (neutral, small effect size). The predominant direction is neutral, with most studies using doses of 200–400 mg/day in varied populations (e.g., clinical GAD, athletes, children). One 70-day RCT reported no effect; evidence does not support a consistent anxiolytic benefit.

Caveats: Many of the included studies (4 of 6) did not reach statistical significance — effect may be smaller than the predominant direction suggests. The two beneficial studies are a systematic review and a narrative review, while the neutral studies include several RCTs with higher evidence scores. Study durations are poorly reported; the only long-term trial (70 days) showed no benefit.

Generated Jul 12, 2026
Doses used in studies
  • mg/day: 200–900 (median 300, IQR 200650) 3 studies
  • mg/kg/day: 3 (median 3, IQR 33) 1 study
Time to effect
Median: 10 weeks · IQR 10 weeks10 weeks · Range 10 weeks10 weeks — Reported in 1 of 6 studies
Safety in these studies
6 of 6 papers
Back to top